KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Immune Response - Humoral (12)

Tuesday
Jul172012

NCT01644968

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Conditions: Advanced Cancer
Sponsors: Providence Health & Services
Phase: I 

Friday
Mar092012

NCT01552681

Baminercept in Sjögren's Syndrome

Conditions: Sjögren's Syndrome
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase: II

Thursday
Dec012011

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 

Tuesday
Apr142009

2008-001974-33

mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Conditions: Uveal Melanoma 
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a

Thursday
Oct162008

NCT00774943

A Study of AMG 557 in Adults With Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus
Sponsors: Amgen
Phase I

Tuesday
Mar252008

NCT00643097

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II

Friday
Apr062007

PA16215

Wednesday
Jan042006

NCT00282308

Tuesday
Aug232005

NCT00135681

Immune Dysregulation in Children and Adults With Asthma

Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a 

Wednesday
Apr132005

2004-004774-85